Fig. 1From: High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patientsDescription of the study participants. BC, breast cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; OC, ovarian cancer; PR, progesterone receptor; TNBC, triple-negative breast cancerBack to article page